Zhongnan Medical Journal Press

Home Results

A total of 36 result was found. Results that relate to Lung cancer

One case of myelosuppression caused by pamiparib in combination with temozolomide in the treatment of small cell lung cancer

Published on Chinese Journal of Pharmacoepidemiology 2024,33(7):824-829.
9775 times 1814 times

YANG Yuchen ZHAO Yuting LI Shiqi GONG Jiayu SU Riguga SUN Yanyan CAI Zhihui

Small cell lung cancer Pamiparib Temozolomide Bone marrow suppression Adverse drug reactions
Details
Research progress of N6-methyladenosine in diseases

Published on Frontiers in Pharmaceutical Sciences 2024,27(8):1436-1444.
7854 times 1461 times

PAN Wang ZHOU Aihua

N6-methyladenosine methylase demethylase Cellular processes Lung cancer Pulmonary fibrosis Renal cell carcinoma Acute kidney injury Asthma Alzheimer's disease Research progress
Details
Pharmaceutical practice of acute liver injury in a patient with nintedanib-induced lung cancer complicated with interstitial pneumonia

Published on Chinese Journal of Pharmacoepidemiology 2024,33(10):1178-1182.
8886 times 1877 times

ZHANG Juan SHEN Lihuan LIU Jiyong WANG Chunmin

Nintedanib Lung cancer with interstitial pneumonia Acute liver injury Pharmaceutical practice
Details
Application of cardiopulmonary exercise testing in the assessment of cardiopulmonary functional changes in lung cancer patients before and after radiotherapy

Published on New Medicine 2024,34(10):1130-1139.
7949 times 1577 times

REN Mengyi JIANG Xiaowei ZHANG Yangmei LI Jin

Lung cancer Radiotherapy Cardiopulmonary exercise testing Cardiopulmonary function
Details
A case of toxic epidermal necrolysis caused by pembrolizumab

Published on Chinese Journal of Pharmacoepidemiology 2024,33(11):1314-1319.
10022 times 1645 times

HUANG Lingling LI Xialin HUANG Guangyao LUO Peng WANG Weimin WANG Junping

Pembrolizumab Lung cancer Toxic epidermal necrolysis Adverse drug reaction
Details
Construction of a nomogram model for the prognosis of advanced non-small cell lung cancer patients treated with microwave ablation combined with immunotherapy based on inflammatory and nutritional indicators

Published on Journal of Mathematical Medicine 2024,37(12):899-911.
10389 times 1466 times

LI Chen XIANG Shiqiang

Non-small cell lung cancer Microwave ablation Immunotherapy Nutritional indicators Inflammatory indicators Nomogram model
Details
Pharmacoeconomic evaluation of third-line treatment of advanced non-small cell lung cancer with anlotinib

Published on Frontiers in Pharmaceutical Sciences 2024,28(4):639-647.
10479 times 1185 times

YUAN Wenjie KANG Shuo WANG Xiaohui GONG Yuan PAN Zhenhua

Anlotinib Pharmacoeconomics Non-small cell lung cancer Cost-utility analysis
Details
Clinical efficacy analysis of cross-line immunotherapy in driver gene-negative advanced non-small cell lung cancer patients

Published on New Medicine 2025,35(2):151-161.
8168 times 1539 times

WANG Yuankun LU Jiahao HU Jing XIE Conghua

Cross-line immunotherapy Non-small cell lung cancer Immune checkpoint inhibitors Prognosis Driver gene-negative
Details
Analysis of influencing factors of cisplatin chemotherapy sensitivity and construction of nomogram model in elderly patients with non-small cell lung cancer

Published on Frontiers in Pharmaceutical Sciences 2025,29(2):284-290.
7333 times 904 times

HE Ting CHEN Jingjing LI Yuling

Elderly Non-small cell lung cancer Cisplatin Chemotherapy sensitivity Influencing factors Nomogram model Predictive efficiency
Details
Mechanism of Salvia miltiorrhiza against non-small cell lung cancer based on network pharmacology

Published on Frontiers in Pharmaceutical Sciences 2025,29(3):361-373.
5481 times 1051 times

TAO Gan GUO Xiuli HE Fajian WU Qiuji ZHONG Yahua

Salvia miltiorrhiza Traditional Chinese medicine Network pharmacology Molecular docking Non-small cell lung cancer
Details
Efficacy and safety of Tislelizumab combined with chemotherapy in the treatment of non-small cell lung cancer: a Meta-analysis

Published on New Medicine 2025,35(4):442-451.
7204 times 1368 times

WANG Kuan TAN Xiao GUO Yanni

Non-small cell lung cancer Tislelizumab Chemotherapy Effectiveness Safety Meta-analysis
Details
Exploration on medication pattern of traditional Chinese medicine treatment for non-small cell lung cancer based on real world data

Published on Chinese Journal of Pharmacoepidemiology 2025,34(4):398-409.
13953 times 3270 times

LI Junya SHI Yanglin YANG Jianya LI Ya LI Suyun

Non-small cell lung cancer Traditional Chinese medicine Real-word data Latent structure model Association rule Medication pattern
Details
Research progress on the structural modification and anti-lung cancer activity of natural product erianin

Published on Frontiers in Pharmaceutical Sciences 2025,29(5):849-858.
6909 times 900 times

LIU Jing ZHANG Na LI Xiaolu ZHAO Bin

Erianin Structural modification Anti-lung cancer Molecular mechanisms Research progress
Details
Efficacy and safety of tislelizumab combined with anlotinib in the treatment of advanced non-small cell lung cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):785-794.
7416 times 967 times

TENG Xinli LIU Bin XIU Junli ZHOU Xiaohong

Tislelizumab Anlotinib Non-small cell lung cancer Meta-analysis Systematic review
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):806-814.
6426 times 927 times

HOU Yibing KANG Shuo GONG Yuan WANG Xiaohui NIE Ying LIU Huanlong

Sugemalimab Non-small cell lung cancer Effectiveness Safety Economics Rapid health technology assessment
Details